Nisa Investment Advisors LLC Increases Position in Citigroup Inc. $C

Nisa Investment Advisors LLC increased its holdings in Citigroup Inc. (NYSE:C) by 3.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 574,835 shares of the company’s stock after purchasing an additional 19,453 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Citigroup were worth $67,077,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of C. Wolff Wiese Magana LLC increased its position in shares of Citigroup by 87.6% in the third quarter. Wolff Wiese Magana LLC now owns 257 shares of the company’s stock valued at $26,000 after buying an additional 120 shares in the last quarter. Dunhill Financial LLC raised its stake in shares of Citigroup by 92.2% during the 3rd quarter. Dunhill Financial LLC now owns 319 shares of the company’s stock worth $32,000 after buying an additional 153 shares during the period. Guerra Advisors Inc purchased a new position in shares of Citigroup during the 3rd quarter valued at approximately $33,000. Howard Hughes Medical Institute purchased a new position in shares of Citigroup during the 2nd quarter valued at approximately $34,000. Finally, Capital A Wealth Management LLC acquired a new stake in Citigroup in the 2nd quarter valued at $38,000. Hedge funds and other institutional investors own 71.72% of the company’s stock.

Insider Transactions at Citigroup

In related news, insider Cantu Ernesto Torres sold 43,173 shares of the company’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $111.09, for a total transaction of $4,796,088.57. Following the completion of the sale, the insider owned 45,835 shares of the company’s stock, valued at approximately $5,091,810.15. This represents a 48.50% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.08% of the company’s stock.

Citigroup Stock Up 5.7%

NYSE C opened at $113.36 on Wednesday. The business has a fifty day moving average price of $112.68 and a 200 day moving average price of $108.36. The company has a debt-to-equity ratio of 1.63, a quick ratio of 1.00 and a current ratio of 1.00. The company has a market cap of $198.31 billion, a P/E ratio of 16.26, a P/E/G ratio of 0.69 and a beta of 1.17. Citigroup Inc. has a one year low of $55.51 and a one year high of $125.16.

Citigroup (NYSE:C) last announced its earnings results on Wednesday, January 14th. The company reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.16. Citigroup had a net margin of 8.50% and a return on equity of 8.28%. The company had revenue of $19.87 billion for the quarter, compared to analysts’ expectations of $20.99 billion. During the same quarter in the previous year, the company posted $1.34 EPS. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. Research analysts anticipate that Citigroup Inc. will post 7.53 EPS for the current fiscal year.

Citigroup Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Monday, February 2nd were given a dividend of $0.60 per share. The ex-dividend date was Monday, February 2nd. This represents a $2.40 dividend on an annualized basis and a yield of 2.1%. Citigroup’s payout ratio is presently 34.43%.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Morgan Stanley set a $152.00 price target on shares of Citigroup in a report on Tuesday, February 17th. Wolfe Research reiterated an “outperform” rating and issued a $141.00 target price on shares of Citigroup in a research report on Wednesday, January 7th. Keefe, Bruyette & Woods boosted their target price on shares of Citigroup from $118.00 to $131.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Oppenheimer reduced their price target on shares of Citigroup from $144.00 to $132.00 and set an “outperform” rating for the company in a research report on Friday, March 27th. Finally, HSBC reaffirmed a “buy” rating and issued a $87.00 price target on shares of Citigroup in a research note on Wednesday, January 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $127.00.

Citigroup News Summary

Here are the key news stories impacting Citigroup this week:

• Positive Sentiment: Market rumors that Citigroup was weighing a U.S. regional‑bank acquisition sparked a selloff but the bank publicly called the reports baseless; the denial and management’s reaffirmation of its organic‑growth strategy helped calm buyers and likely contributed to the rebound in the share price. QuiverQuant: Citigroup Stock Opinions
• Positive Sentiment: Analyst coverage remains constructive overall: the consensus of recent analyst notes shows multiple buy/overweight ratings and a median 12‑month target near ~$131, providing a supportive research backdrop even as price targets are being adjusted. (This helps explain why dips have found buyers.) QuiverQuant: Analyst & target summary
• Neutral Sentiment: Press reports note management is exploring next strategic moves under CEO Jane Fraser — including speculative interest in regional deals — which could be growth‑positive long term but would bring execution and regulatory risk if pursued. The Star: Citigroup eyes regional bank deal
• Neutral Sentiment: Small, technical disclosure: Citigroup group entities ceased to be substantial holders in Australia’s Mayne Pharma — a housekeeping/regulatory filing with negligible operational impact on Citi. TipRanks: Substantial holder notice
• Negative Sentiment: Insider selling (multiple exec sales reported) and large institutional reductions disclosed in recent filings are a cautionary signal for some investors—these disclosures have been highlighted in market commentary and can amplify short‑term downside on weak news. QuiverQuant: Insider & institutional activity
• Negative Sentiment: Oppenheimer trimmed its price target for Citigroup to $132 — a modest downtick that may temper upside for some investors and feed short‑term headlines, though the new target remains within the range of street estimates. AmericanBankingNews: Oppenheimer cuts target

About Citigroup

Citigroup Inc is a global financial services company headquartered in New York City with roots tracing back to the City Bank of New York, founded in 1812. The modern Citigroup was created through the 1998 merger of Citicorp and Travelers Group and has since operated as a diversified bank holding company that provides a broad range of banking and financial products and services to consumers, corporations, governments and institutions worldwide.

Citi’s principal businesses include retail and commercial banking, credit card and consumer lending products, wealth management and private banking, and a full suite of institutional services.